SERPINA4 and metabolic dysfunction-associated steatotic liver disease: Conversely, Serpina4−/− alone had no effect on lipid metabolism and liver lesions, but ameliorated hepatic steatosis and inflammation in HFruD and MCD induced NAFLD rats.